These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Path analysis of biomarkers for cognitive decline in early Parkinson's disease. Gramotnev DK; Gramotnev G; Gramotnev A; Summers MJ PLoS One; 2022; 17(5):e0268379. PubMed ID: 35560326 [TBL] [Abstract][Full Text] [Related]
5. Patient and Clinician Impressions of Cognitive Impairment in Parkinson's Disease. Ngo AB; Smith KM J Parkinsons Dis; 2020; 10(4):1695-1698. PubMed ID: 32925096 [TBL] [Abstract][Full Text] [Related]
6. Cognitive profiles and optimal cut-offs for routine cognitive tests in elderly individuals with Parkinson's disease, Parkinson's disease dementia, Alzheimer's disease, and normal cognition. Phannarus H; Muangpaisan W; Siritipakorn P; Chotinaiwattarakul W Psychogeriatrics; 2020 Jan; 20(1):20-27. PubMed ID: 30912230 [TBL] [Abstract][Full Text] [Related]
7. Urate and Homocysteine: Predicting Motor and Cognitive Changes in Newly Diagnosed Parkinson's Disease. Sleeman I; Lawson RA; Yarnall AJ; Duncan GW; Johnston F; Khoo TK; Burn DJ J Parkinsons Dis; 2019; 9(2):351-359. PubMed ID: 30909247 [TBL] [Abstract][Full Text] [Related]
8. Predict cognitive decline with clinical markers in Parkinson's disease (PRECODE-1). Wilson H; Pagano G; Yousaf T; Polychronis S; De Micco R; Giordano B; Niccolini F; Politis M J Neural Transm (Vienna); 2020 Jan; 127(1):51-59. PubMed ID: 31853652 [TBL] [Abstract][Full Text] [Related]
9. An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF Aß42 and an APOE ε4 allele. Shahid M; Kim J; Leaver K; Hendershott T; Zhu D; Cholerton B; Henderson VW; Tian L; Poston KL Neurobiol Dis; 2019 Jul; 127():278-286. PubMed ID: 30826425 [TBL] [Abstract][Full Text] [Related]
10. Subjective cognitive decline predicts future deterioration in cognitively normal patients with Parkinson's disease. Hong JY; Sunwoo MK; Chung SJ; Ham JH; Lee JE; Sohn YH; Lee PH Neurobiol Aging; 2014 Jul; 35(7):1739-43. PubMed ID: 24507441 [TBL] [Abstract][Full Text] [Related]
11. Blood Biomarkers Associated with Cognitive Decline in Early Stage and Drug-Naive Parkinson's Disease Patients. Santiago JA; Potashkin JA PLoS One; 2015; 10(11):e0142582. PubMed ID: 26566043 [TBL] [Abstract][Full Text] [Related]
12. Senescence and Inflammatory Markers for Predicting Clinical Progression in Parkinson's Disease: The ICICLE-PD Study. Martin-Ruiz C; Williams-Gray CH; Yarnall AJ; Boucher JJ; Lawson RA; Wijeyekoon RS; Barker RA; Kolenda C; Parker C; Burn DJ; Von Zglinicki T; Saretzki G J Parkinsons Dis; 2020; 10(1):193-206. PubMed ID: 31868677 [TBL] [Abstract][Full Text] [Related]
13. An assessment of Movement Disorder Society Task Force diagnostic criteria for mild cognitive impairment in Parkinson's disease. Uysal-Cantürk P; Hanağası HA; Bilgiç B; Gürvit H; Emre M Eur J Neurol; 2018 Jan; 25(1):148-153. PubMed ID: 28941002 [TBL] [Abstract][Full Text] [Related]
14. Subjective cognitive decline and progression to dementia in Parkinson's disease: a long-term follow-up study. Galtier I; Nieto A; Lorenzo JN; Barroso J J Neurol; 2019 Mar; 266(3):745-754. PubMed ID: 30635723 [TBL] [Abstract][Full Text] [Related]
15. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease. Ray NJ; Bradburn S; Murgatroyd C; Toseeb U; Mir P; Kountouriotis GK; Teipel SJ; Grothe MJ Brain; 2018 Jan; 141(1):165-176. PubMed ID: 29228203 [TBL] [Abstract][Full Text] [Related]
16. Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting. Almuqbel M; Melzer TR; Myall DJ; MacAskill MR; Pitcher TL; Livingston L; Wood KL; Keenan RJ; Dalrymple-Alford JC; Anderson TJ Parkinsonism Relat Disord; 2016 Jan; 22():54-61. PubMed ID: 26627939 [TBL] [Abstract][Full Text] [Related]
18. Biomarkers of cognitive decline in Parkinson's disease. Lin CH; Wu RM Parkinsonism Relat Disord; 2015 May; 21(5):431-43. PubMed ID: 25737398 [TBL] [Abstract][Full Text] [Related]
19. Longitudinal changes in cognition in early Parkinson's disease patients with REM sleep behavior disorder. Chahine LM; Xie SX; Simuni T; Tran B; Postuma R; Amara A; Oertel WH; Iranzo A; Scordia C; Fullard M; Linder C; Purri R; Darin A; Rennert L; Videnovic A; Del Riva P; Weintraub D Parkinsonism Relat Disord; 2016 Jun; 27():102-6. PubMed ID: 27010070 [TBL] [Abstract][Full Text] [Related]
20. Do dreams tell the future? Dream content as a predictor of cognitive deterioration in Parkinson's disease. Bugalho P; Ladeira F; Barbosa R; Marto JP; Borbinha C; Salavisa M; da Conceição L; Saraiva M; Fernandes M; Meira B J Sleep Res; 2021 Jun; 30(3):e13163. PubMed ID: 32776436 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]